-
1
-
-
0033549530
-
Nitric oxide: A unique endogenous signaling molecule in vascular biology
-
Ignarro, L.J., "Nitric oxide: A unique endogenous signaling molecule in vascular biology," Angew. Chem Int. Educ., 38, 1882-1892(1999).
-
(1999)
Angew. Chem Int. Educ.
, vol.38
, pp. 1882-1892
-
-
Ignarro, L.J.1
-
2
-
-
0019195506
-
The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
-
Furchgott, R.F. and Zawadzki, J.V., "The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine," Nature, 288, 373-376(1980).
-
(1980)
Nature
, vol.288
, pp. 373-376
-
-
Furchgott, R.F.1
Zawadzki, J.V.2
-
3
-
-
0022481682
-
Cyclic guanosine monophosphate as a mediator of vasodilation
-
Murad, F., "Cyclic guanosine monophosphate as a mediator of vasodilation," J. Clin. Invest., 78, 1-5(1986).
-
(1986)
J. Clin. Invest.
, vol.78
, pp. 1-5
-
-
Murad, F.1
-
4
-
-
0028220671
-
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
-
Bolotina, V.M., Najibi, S., Palacino, J.J., Pagano, P.J. and Cohen, R.A., "Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle," Nature, 368, 850-853(1994).
-
(1994)
Nature
, vol.368
, pp. 850-853
-
-
Bolotina, V.M.1
Najibi, S.2
Palacino, J.J.3
Pagano, P.J.4
Cohen, R.A.5
-
5
-
-
0027935877
-
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
-
Archer, S.L., Huang J.M.-C., Hampl, V., Nelson, D.P., Schultz, P.J. and Weir, E.K., "Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase," Proc. Natl. Acad Sci. (USA), 91, 7583-7587(1994).
-
(1994)
Proc. Natl. Acad Sci. (USA)
, vol.91
, pp. 7583-7587
-
-
Archer, S.L.1
Huang, J.M.-C.2
Hampl, V.3
Nelson, D.P.4
Schultz, P.J.5
Weir, E.K.6
-
6
-
-
0001917060
-
Drugs used for the treatment of myocardial ischemia
-
(edit. Hardman, J.G., Limbird, L.E., and Gilman, A.G.), McGraw-Hill, New York
-
Kerins, D. M., Robertson, R.M. and Robertson, D., "Drugs used for the treatment of myocardial ischemia," in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed., (edit. Hardman, J.G., Limbird, L.E., and Gilman, A.G.), McGraw-Hill, New York (2001) pp. 843-870.
-
(2001)
Goodman and Gilman's the Pharmacological Basis of Therapeutics, 10th Ed.
, pp. 843-870
-
-
Kerins, D.M.1
Robertson, R.M.2
Robertson, D.3
-
7
-
-
0000179729
-
Vasodilators and the treatment of angina pectoris
-
(edit. Katzung, B.C.) McGraw-Hill, New York
-
Katzung, B.G., and Chatterjee, K., "Vasodilators and the treatment of angina pectoris," In Basic and Clinical Pharmacology, 8th ed., (edit. Katzung, B.C.) McGraw-Hill, New York (2001) pp. 181-199.
-
(2001)
Basic and Clinical Pharmacology, 8th Ed.
, pp. 181-199
-
-
Katzung, B.G.1
Chatterjee, K.2
-
8
-
-
0035818534
-
Tolerance to the organic nitrates: New ideas, new mechanisms, continued mystery
-
Parker, J.D. and Gori, T., "Tolerance to the organic nitrates: New ideas, new mechanisms, continued mystery," Circulation, 104, 2263-2265(2001).
-
(2001)
Circulation
, vol.104
, pp. 2263-2265
-
-
Parker, J.D.1
Gori, T.2
-
9
-
-
0032545984
-
Nitrate therapy for stable angina pectoris
-
Parker, J.D. and Parker, J.O., "Nitrate therapy for stable angina pectoris," N. Eng. J. Med, 338, 520-531(1998).
-
(1998)
N. Eng. J. Med
, vol.338
, pp. 520-531
-
-
Parker, J.D.1
Parker, J.O.2
|